• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

身高降低率作为类风湿性关节炎绝经后女性骨质疏松症的一项指标

Height loss rate as a marker of osteoporosis in postmenopausal women with rheumatoid arthritis.

作者信息

Sanila M, Kotaniemi A, Viikari J, Isomäki H

机构信息

Rheumatism Foundation Hospital, Heinola, Finland.

出版信息

Clin Rheumatol. 1994 Jun;13(2):256-60. doi: 10.1007/BF02249022.

DOI:10.1007/BF02249022
PMID:8088069
Abstract

The relation between the loss of height and bone mineral density (BMD) at the lumbar spine and proximal femur was determined in 61 women aged 56-70 years suffering from rheumatoid arthritis. Statistically highly significant negative correlations were found between the loss of height and the spinal and femoral BMD. A loss of 4 cm or more in height over 10 years seems to be associated with a significant decrease of BMD, and it can be recommended as a clinical marker of osteoporosis.

摘要

对61名年龄在56至70岁之间的类风湿性关节炎女性患者，测定了身高降低与腰椎和股骨近端骨矿物质密度（BMD）之间的关系。结果发现，身高降低与脊柱和股骨的骨矿物质密度之间存在统计学上高度显著的负相关。10年内身高降低4厘米或更多，似乎与骨矿物质密度的显著下降有关，可作为骨质疏松症的临床指标。

相似文献

1
Height loss rate as a marker of osteoporosis in postmenopausal women with rheumatoid arthritis.身高降低率作为类风湿性关节炎绝经后女性骨质疏松症的一项指标
Clin Rheumatol. 1994 Jun;13(2):256-60. doi: 10.1007/BF02249022.
2
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.一项关于类风湿关节炎骨密度的多中心横断面研究。意大利类风湿关节炎骨量研究组。
J Rheumatol. 2000 Nov;27(11):2582-9.
3
Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.科威特最大省份的绝经后科威特女性居民中低骨量的流行情况。
Arch Osteoporos. 2012;7:147-53. doi: 10.1007/s11657-012-0092-1. Epub 2012 Sep 1.
4
[Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].[通过数字X线摄影术鉴别类风湿关节炎患者皮质激素性骨质疏松和关节周围脱矿质的临床试验]
Z Rheumatol. 2004 Dec;63(6):473-82. doi: 10.1007/s00393-004-0632-1.
5
Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.口服每日一次的伊班膦酸盐可预防无骨质疏松症的绝经后早期女性骨质流失。
J Bone Miner Res. 2004 Jan;19(1):11-8. doi: 10.1359/JBMR.0301202.
6
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes.股骨近端和脊柱骨密度随年龄的变化。绝经后骨质疏松症和老年性骨质疏松症综合征之间的差异。
J Clin Invest. 1982 Oct;70(4):716-23. doi: 10.1172/jci110667.
7
The effect of circulating nitric oxide level on axial bone mineral density in postmenopausal Turkish women with rheumatoid arthritis: A preliminary report.循环一氧化氮水平对患有类风湿性关节炎的绝经后土耳其女性轴向骨矿物质密度的影响：初步报告。
Rheumatol Int. 2006 Jul;26(9):805-9. doi: 10.1007/s00296-005-0091-2. Epub 2005 Dec 14.
8
Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.在类风湿关节炎相关性骨质疏松症中，无论是否进行双膦酸盐预处理，地诺单抗均可显著提高骨密度：地诺单抗可提高类风湿关节炎相关性骨质疏松症的骨密度。
Arch Osteoporos. 2017 Sep 21;12(1):80. doi: 10.1007/s11657-017-0371-y.
9
Bone mineral density of vertebrae, proximal femur and os calcis in normal Greek subjects as assessed by dual-energy X-ray absorptiometry: comparison with other populations.通过双能X线吸收法评估的正常希腊受试者的椎骨、股骨近端和跟骨的骨密度：与其他人群的比较。
Eur J Clin Invest. 1997 Mar;27(3):219-27. doi: 10.1046/j.1365-2362.1997.980636.x.
10
Bone mineral density in healthy Dutch women: spine and hip measurements using dual-energy X-ray absorptiometry.健康荷兰女性的骨密度：使用双能X线吸收测定法测量脊柱和髋部
Neth J Med. 1994 Nov;45(5):198-205.

本文引用的文献

1
Fractures after rheumatoid arthritis. A population-based study.类风湿关节炎后的骨折。一项基于人群的研究。
Arthritis Rheum. 1984 Dec;27(12):1353-61. doi: 10.1002/art.1780271205.
2
Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.类风湿关节炎中的骨质疏松症：低剂量皮质类固醇的安全性
Ann Rheum Dis. 1986 Nov;45(11):950-3. doi: 10.1136/ard.45.11.950.
3
Comparisons among methods of measuring bone mass and relationship to severity of vertebral fractures in osteoporosis.骨质疏松症中骨量测量方法的比较及其与椎体骨折严重程度的关系。
J Clin Endocrinol Metab. 1988 Mar;66(3):501-7. doi: 10.1210/jcem-66-3-501.
4
Assessment of loss of height in elderly women.老年女性身高降低情况的评估。
Eur J Clin Nutr. 1988 Aug;42(8):679-82.
5
A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis.一种新开发的脊柱畸形指数（SDI），用于量化骨质疏松症患者的椎体压缩骨折。
Bone Miner. 1988 Mar;3(4):335-49.
6
Stature loss among an older United States population and its relation to bone mineral status.美国老年人群的身高降低及其与骨矿物质状况的关系。
Am J Phys Anthropol. 1990 Dec;83(4):467-76. doi: 10.1002/ajpa.1330830408.
7
Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy.类风湿关节炎患者的椎体骨质疏松：低剂量泼尼松治疗的效果
Br J Rheumatol. 1992 Feb;31(2):91-6. doi: 10.1093/rheumatology/31.2.91.
8
Hip mineral density in females with a recent hip fracture.近期发生髋部骨折的女性的髋部骨密度
J Clin Endocrinol Metab. 1992 Feb;74(2):351-6. doi: 10.1210/jcem.74.2.1730813.
9
Fracture thresholds in osteoporosis: implications for hormone replacement treatment.骨质疏松症中的骨折阈值：对激素替代治疗的影响。
Ann Rheum Dis. 1992 Sep;51(9):1063-5. doi: 10.1136/ard.51.9.1063.